We are live on ! Find out more
LI

LRI Investments Portfolio holdings

AUM $1.24B
1-Year Est. Return 11.13%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+11.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.24B
AUM Growth
+$16.4M
Cap. Flow
-$10.6M
Cap. Flow %
-0.86%
Top 10 Hldgs %
57.73%
Holding
1,424
New
115
Increased
242
Reduced
323
Closed
69

Sector Composition

Rank Sector Weight
1 Financials 33.57%
2 Technology 6.43%
3 Industrials 3.31%
4 Consumer Discretionary 2.02%
5 Healthcare 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBD icon
1326
Banco Bradesco
BBD
$36.3B
$396 ﹤0.01%
119
CLSK icon
1327
CleanSpark
CLSK
$3.01B
$385 ﹤0.01%
+38
New +$570
MRNA icon
1328
Moderna
MRNA
$23.7B
$383 ﹤0.01%
13
INDA icon
1329
iShares MSCI India ETF
INDA
$6.6B
$378 ﹤0.01%
7
QGEN icon
1330
Qiagen
QGEN
$9.05B
$365 ﹤0.01%
8
PACB icon
1331
Pacific Biosciences
PACB
$351M
$318 ﹤0.01%
+170
New +$327
IHG icon
1332
InterContinental Hotels
IHG
$22.9B
$282 ﹤0.01%
2
LPL icon
1333
LG Display
LPL
$3.39B
$281 ﹤0.01%
67
OGN icon
1334
Organon & Co
OGN
$3.58B
$280 ﹤0.01%
39
-569
-94% -$4.5K
XRX icon
1335
Xerox
XRX
$425M
$280 ﹤0.01%
118
+85
+258% +$252
ING icon
1336
ING
ING
$101B
$252 ﹤0.01%
9
BAK icon
1337
Braskem
BAK
$901M
$195 ﹤0.01%
66
NWL icon
1338
Newell Brands
NWL
$2.52B
$187 ﹤0.01%
50
ANGI icon
1339
Angi Inc
ANGI
$186M
$142 ﹤0.01%
11
PASG icon
1340
Passage Bio
PASG
$14.5M
$142 ﹤0.01%
12
TVRD
1341
Tvardi Therapeutics
TVRD
$22.1M
$116 ﹤0.01%
27
-55
-67% -$493
WDS icon
1342
Woodside Energy
WDS
$43.9B
$109 ﹤0.01%
7
JXN icon
1343
Jackson Financial
JXN
$8.94B
$107 ﹤0.01%
1
FG icon
1344
F&G Annuities & Life
FG
$3.54B
$93 ﹤0.01%
+3
New +$94
FSLY icon
1345
Fastly Inc
FSLY
$4.41B
$51 ﹤0.01%
5
NKTR icon
1346
Nektar Therapeutics
NKTR
$2.52B
$42 ﹤0.01%
1
NOTE
1347
DELISTED
FiscalNote
NOTE
$37 ﹤0.01%
25
AGIG
1348
Abundia Global Impact Group
AGIG
$39.1M
$24 ﹤0.01%
12
PEY icon
1349
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.16B
$20 ﹤0.01%
1
FLNA
1350
Filana Therapeutics
FLNA
$48.3M
$20 ﹤0.01%
10

Similar funds

LRI Investments's Q4 2025 Portfolio in Review

As of Q4 2025, LRI Investments held 1,424 positions worth $1.24B, up 1.3% from $1.22B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

LRI Investments's Q4 2025 filing shows 115 new, 242 increased, 323 reduced and 69 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 217,176 shares worth $16.4M. The largest sale was Ares Management, an estimated $30.4M.

By sector, the portfolio is most concentrated in Financials at 34% of assets, down from 36% a quarter earlier, followed by Technology and Industrials.

  • LRI Investments's largest Q4 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 217,176 shares worth $16.4M.
  • LRI Investments added most to Dimensional US Core Equity 1 ETF in Q4 2025, an estimated $6.59M increase.
  • LRI Investments's biggest Q4 2025 reduction was Ares Management, cutting an estimated $30.4M.
  • LRI Investments fully exited FT Vest S&P 500 Dividend Aristocrats Target Income ETF in Q4 2025, selling an estimated $690K.
  • LRI Investments's ten largest holdings make up 58% of its $1.24B portfolio in Q4 2025.
  • LRI Investments opened 115 new positions and closed 69 in Q4 2025.
  • LRI Investments's portfolio value rose 1.3% quarter-over-quarter to $1.24B.

Based on LRI Investments's 13F filing for Q4 2025, filed 4 Feb 2026.